A real-world study of the treatment of functional dyspepsia in children with Bow Ji oral liquid

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069106

Enrollment

Unknown

Registered

2023-03-07

Start date

2023-03-15

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia in children

Interventions

Baoji oral liquid or Baoji oral liquid + Western medicine conventional treatment:not

Western medicine conventional treatment:not

Eligibility

Sex/Gender

All

Age

0.3 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Previous history of functional dyspepsia in children (meets the Western diagnostic criteria for functional dyspepsia in children/infants) (2) Patients with nausea/vomiting or diarrhea symptoms (3) Age 4 months ~ 14 years old; (4) Except for patients with red tongue, moss yellow, and dry stool, who belong to Bristol type 1, 2, and 3; (5) Except those who are allergic to research drugs; (6) The informed consent process should be compliant.

Exclusion criteria

Exclusion criteria: not

Design outcomes

Primary

Measure	Time frame
FD symptoms are combined;Disappearance rate of individual FD symptoms;Incidence of adverse events/adverse reactions;	—

Secondary

Measure	Time frame
Rate of symptom relapse;	—

Countries

China

Contacts

Public ContactYan Yongbin

The First Affiliated Hospital of Henan University of Chinese Medicine

huyuyang@zyyjypj.cn15130720851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026